J. Mackowski Biography and Net Worth

Director of Alpha Teknova


J. Matthew Mackowski has served as a director since January 2019. Matthew is Chairman and Managing Director of Telegraph Hill Partners, which he co-founded in 2001. Telegraph Hill Partners is a venture capital firm that takes an active role in developing technology-based growth companies in the life sciences, medical device, and healthcare industries, and has invested in 39 companies across four institutionally funded limited partnerships. Matthew formed Mackowski & Shepler, the predecessor to Telegraph Hill Partners, in 1992 and over nine years took an active or founding role with eight companies, primarily in medical and life science technologies. He received a bachelor’s degree from Duke University and an MBA from The Wharton School.

What is J. Matthew Mackowski's net worth?

The estimated net worth of J. Matthew Mackowski is at least $3.92 million as of September 19th, 2023. Mr. Mackowski owns 810,810 shares of Alpha Teknova stock worth more than $3,916,212 as of December 5th. This net worth evaluation does not reflect any other investments that Mr. Mackowski may own. Learn More about J. Matthew Mackowski's net worth.

How do I contact J. Matthew Mackowski?

The corporate mailing address for Mr. Mackowski and other Alpha Teknova executives is , , . Alpha Teknova can also be reached via phone at 831-637-1100 and via email at [email protected]. Learn More on J. Matthew Mackowski's contact information.

Has J. Matthew Mackowski been buying or selling shares of Alpha Teknova?

J. Matthew Mackowski has not been actively trading shares of Alpha Teknova during the past quarter. Most recently, on Tuesday, September 19th, J Matthew Mackowski bought 810,810 shares of Alpha Teknova stock. The stock was acquired at an average cost of $1.85 per share, with a total value of $1,499,998.50. Following the completion of the transaction, the director now directly owns 810,810 shares of the company's stock, valued at $1,499,998.50. Learn More on J. Matthew Mackowski's trading history.

Who are Alpha Teknova's active insiders?

Alpha Teknova's insider roster includes Martha Demski (Director), Ken Gelhaus (Insider), Stephen Gunstream (CEO), Matthew Lowell (CFO), J. Mackowski (Director), and Damon Terrill (General Counsel). Learn More on Alpha Teknova's active insiders.

Are insiders buying or selling shares of Alpha Teknova?

In the last twelve months, insiders at the sold shares 1 times. They sold a total of 8,000 shares worth more than $40,480.00. The most recent insider tranaction occured on June, 27th when Director Martha J Demski sold 8,000 shares worth more than $40,480.00. Insiders at Alpha Teknova own 12.5% of the company. Learn More about insider trades at Alpha Teknova.

Information on this page was last updated on 6/27/2025.

J. Matthew Mackowski Insider Trading History at Alpha Teknova

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2023Buy810,810$1.85$1,499,998.50810,810View SEC Filing Icon  
8/24/2022Buy10,000$4.97$49,700.005,000View SEC Filing Icon  
See Full Table

J. Matthew Mackowski Buying and Selling Activity at Alpha Teknova

This chart shows J Matthew Mackowski's buying and selling at Alpha Teknova by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alpha Teknova Company Overview

Alpha Teknova logo
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Read More

Today's Range

Now: $4.83
Low: $4.70
High: $4.87

50 Day Range

MA: $5.09
Low: $4.28
High: $6.37

2 Week Range

Now: $4.83
Low: $3.94
High: $10.37

Volume

66,052 shs

Average Volume

166,336 shs

Market Capitalization

$258.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4